Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on June 14, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print June 14, 2007, doi: 10.1161/ATVBAHA.107.141291
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/9/2030    most recent
ATVBAHA.107.141291v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luke, M. M.
Right arrow Articles by Ellis, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luke, M. M.
Right arrow Articles by Ellis, S. G.

Submitted on February 5, 2007
Accepted on May 23, 2007

A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease

May M. Luke *; John P. Kane ; Dongming M. Liu ; Charles M. Rowland ; Dov Shiffman ; June Cassano ; Joseph J. Catanese ; Clive R. Pullinger ; Diane U. Leong ; Andre R. Arellano ; Carmen H. Tong ; Irina Movsesyan ; Josephina Naya-Vigne ; Curtis Noordhof ; Nicole T. Feric ; Mary J. Malloy ; Eric J. Topol ; Marlys L. Koschinsky ; James J. Devlin ; and Stephen G. Ellis

From Celera (M.M.L., D.M.L., C.M.R., D.S., J.J.C., D.U.L., A.R.A., C.H.T., J.J.D.), Alameda, Calif; the Cardiovascular Research Institute (J.P.K., C.R.P., I.M., J.N.-V., M.J.M.), UCSF, San Francisco, Calif; The Cleveland Clinic Foundation, Department of Cardiovascular Medicine (J.C., E.J.T., S.G.E.), Cleveland, Ohio; the Department of Biochemistry (C.N., N.T.F., M.L.K.), Queen’s University, Kingston, Ontario, Canada; and The Scripps Research Institute (E.J.T.), La Jolla, Calif.

* To whom correspondence should be addressed. E-mail: may.luke{at}celera.com.

Objectives--The purpose of this study was to identify genetic variants associated with severe coronary artery disease (CAD).

Methods and Results--We used 3 case-control studies of white subjects whose severity of CAD was assessed by angiography. The first 2 studies were used to generate hypotheses that were then tested in the third study. We tested 12 077 putative functional single nucleotide polymorphisms (SNPs) in Study 1 (781 cases, 603 controls) and identified 302 SNPs nominally associated with severe CAD. Testing these 302 SNPs in Study 2 (471 cases, 298 controls), we found 5 (in LPA, CALM1, HAP1, AP3B1, and ABCG2) were nominally associated with severe CAD and had the same risk alleles in both studies. We then tested these 5 SNPs in Study 3 (554 cases, 373 controls). We found 1 SNP that was associated with severe CAD: LPA I4399M (rs3798220). LPA encodes apolipoprotein(a), a component of lipoprotein(a). I4399M is located in the protease-like domain of apolipoprotein(a). Compared with noncarriers, carriers of the 4399M risk allele (2.7% of controls) had an adjusted odds ratio for severe CAD of 3.14 (confidence interval 1.51 to 6.56), and had 5-fold higher median plasma lipoprotein(a) levels (P=0.003).

Conclusions--The LPA I4399M SNP is associated with severe CAD and plasma lipoprotein(a) levels.


Key words: coronary arteriosclerosis • genetics • single nucleotide polymorphism • lipoprotein(a) • risk factors